ArticleMolecular and clinical oncology2013

Erlotinib for elderly patients with non-small-cell lung cancer: Subset analysis from a population-based observational study by the Ibaraki Thoracic Integrative (POSITIVE) Research Group.

Koichi Kurishima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.